PharmaEngine Balance Sheet Health
Financial Health criteria checks 6/6
PharmaEngine has a total shareholder equity of NT$3.9B and total debt of NT$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NT$4.0B and NT$91.0M respectively. PharmaEngine's EBIT is NT$277.2M making its interest coverage ratio -5.1. It has cash and short-term investments of NT$3.6B.
Key information
0%
Debt to equity ratio
NT$0
Debt
Interest coverage ratio | -5.1x |
Cash | NT$3.63b |
Equity | NT$3.86b |
Total liabilities | NT$91.01m |
Total assets | NT$3.95b |
Recent financial health updates
No updates
Recent updates
Would PharmaEngine, Inc. (GTSM:4162) Be Valuable To Income Investors?
Mar 30How Much Did PharmaEngine's(GTSM:4162) Shareholders Earn From Share Price Movements Over The Last Five Years?
Feb 18Is PharmaEngine, Inc.'s (GTSM:4162) Stock On A Downtrend As A Result Of Its Poor Financials?
Jan 14We're Not Counting On PharmaEngine (GTSM:4162) To Sustain Its Statutory Profitability
Dec 10Financial Position Analysis
Short Term Liabilities: 4162's short term assets (NT$3.9B) exceed its short term liabilities (NT$83.9M).
Long Term Liabilities: 4162's short term assets (NT$3.9B) exceed its long term liabilities (NT$7.1M).
Debt to Equity History and Analysis
Debt Level: 4162 is debt free.
Reducing Debt: 4162 has not had any debt for past 5 years.
Debt Coverage: 4162 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 4162 has no debt, therefore coverage of interest payments is not a concern.